Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04893265 · ClinicalTrials.gov registry record · NA
Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination
A NA study of Educational Activities, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 247
- Enrollment target
- 3
- Study locations
NCT04893265 is a NA study of Educational Activities that has completed, run by University of California, San Francisco. The registered enrollment target is 247 participants. The trial reports 3 study locations across 1 state.
The verdict
NCT04893265, a NA study of Educational Activities, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 247 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study develops and evaluates the "INdividual and Family-Oriented Responsive Messaging EDucation" (INFORMED) intervention in increasing knowledge about COVID-19 testing and decreasing decisional conflicts of getting tested for COVID-19. A 2-arm randomized controlled trial will compare INFORMED delivered by LHW educational outreach plus Short Message Service (SMS) text messaging to SMS text with LHW support.
Conditions Studied
Interventions
- BEHAVIORAL Text Messaging Only
- BEHAVIORAL INFORMED
Study Locations (3)
California
- The Fresno Center - Fresno
- Chinese Community Health Resource Center - San Francisco
- Immigrant Resettlement & Cultural Center Inc - San Jose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2021-09-30 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04893265
The ClinicalTrials.gov registry entry for NCT04893265 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 247 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Educational Activities appearing as the primary indexed condition, and to 2 interventions - of which Text Messaging Only is the first listed.
NCT04893265 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04893265 about?
NCT04893265 is a clinical study titled "Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination". This study develops and evaluates the "INdividual and Family-Oriented Responsive Messaging EDucation" (INFORMED) intervention in increasing knowledge about COVID-19 testing and decreasing decisional conflicts of getting tested for COVID-19. A 2-arm randomized controlled trial will compare INFORMED d...
What is the current status of trial NCT04893265?
This trial is currently completed. It is a NA study. The enrollment target is 247 participants. The study started on 2021-09-30. Estimated completion is 2024-06-30.
What conditions does trial NCT04893265 study?
This clinical trial studies the following conditions: Educational Activities.
What interventions are being tested in trial NCT04893265?
The interventions under investigation include: Text Messaging Only (BEHAVIORAL), INFORMED (BEHAVIORAL).
Who is sponsoring clinical trial NCT04893265?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04893265 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Educational Activities
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.